Case report: Cryoablation as a novel bridging strategy prior to CAR-T cell therapy for B cell malignancies with bulky disease

Chimeric antigen receptor (CAR) T-cell therapy has emerged as a powerful immunotherapy in relapsed/refractory (R/R) hematological malignancies, especially in R/R B-cell acute lymphocytic leukemia (B-ALL), non-Hodgkin lymphoma (NHL), and multiple myeloma (MM). To prevent disease progression and reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaomin, Wu, Jinming, Qiao, Liangliang, Chen, Lixuan, Chen, Chaolin, Zhang, Hui, Luo, Rongcheng, Xiao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911860/
https://www.ncbi.nlm.nih.gov/pubmed/36776338
http://dx.doi.org/10.3389/fonc.2023.1008828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911860/
https://www.ncbi.nlm.nih.gov/pubmed/36776338
http://dx.doi.org/10.3389/fonc.2023.1008828

Ejemplares similares